Status:
TERMINATED
Chemically Assisted Capsulectomy-A New Clinical Approach
Lead Sponsor:
Vanderbilt University
Conditions:
Implant Capsular Contracture
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to make available an agent,Mesna, which can assist the surgeon during the procedure of capsulectomy.
Detailed Description
Mesna is a FDA approved drug for the treatment of respiratory diseases and is used a protective agent against drugs in oncology patients. It has also been used in Gynecologic surgery and ENT. Mesna is...
Eligibility Criteria
Inclusion
- All females undergoing capsulectomy
Exclusion
- All pregnant women and nursing mothers will be exclued
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00758667
Start Date
January 1 2005
End Date
December 1 2009
Last Update
December 10 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.